{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:35:55Z","timestamp":1790015755058,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["ISR-17-10189"],"award-info":[{"award-number":["ISR-17-10189"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA044874"],"award-info":[{"award-number":["K23DA044874"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DP2DA056107"],"award-info":[{"award-number":["DP2DA056107"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K24DA037109"],"award-info":[{"award-number":["K24DA037109"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30AI060354"],"award-info":[{"award-number":["P30AI060354"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32AI007433"],"award-info":[{"award-number":["T32AI007433"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10461-024-04435-7","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T14:02:26Z","timestamp":1720620146000},"page":"3373-3380","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Leveraging A Digital Pill System to Understand Prevention-Effective Adherence to Oral Hiv Pre-Exposure Prophylaxis Among Men Who Have Sex with Men with Substance Use"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0955-4117","authenticated-orcid":false,"given":"Peter R.","family":"Chai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia R.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassir","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Bustamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Albrechta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany R.","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kel","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Hokayem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle K.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth H.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conall","family":"O\u2019Cleirigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"issue":"151","key":"4435_CR1","doi-asserted-by":"publisher","first-page":"ra151125","DOI":"10.1126\/scitranslmed.3004006","volume":"4","author":"PL Anderson","year":"2012","unstructured":"Anderson PL, Glidden DV, Liu A, et al. Emtricitabine-Tenofovir exposure and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):ra151125\u2013151125. https:\/\/doi.org\/10.1126\/scitranslmed.3004006.","journal-title":"Sci Transl Med"},{"issue":"2","key":"4435_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s40506-015-0046-4","volume":"7","author":"S Doblecki-Lewis","year":"2015","unstructured":"Doblecki-Lewis S, Cohen S, Liu A. Clinical treatment options infectious diseases: update on PrEP implementation, adherence, and advances in delivery. Curr Treat Options Infect Dis. 2015;7(2):101\u201312. https:\/\/doi.org\/10.1007\/s40506-015-0046-4.","journal-title":"Curr Treat Options Infect Dis"},{"issue":"7","key":"4435_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1056\/NEJMoa2101016","volume":"385","author":"RJ Landovitz","year":"2021","unstructured":"Landovitz RJ, Donnell D, Clement ME, et al. Cabotegravir for HIV Prevention in Cisgender men and Transgender women. N Engl J Med. 2021;385(7):595\u2013608. https:\/\/doi.org\/10.1056\/NEJMoa2101016.","journal-title":"N Engl J Med"},{"issue":"3","key":"4435_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/QAI.0000000000001914","volume":"80","author":"TB Wray","year":"2019","unstructured":"Wray TB, Chan PA, Kahler CW, Simpanen EM, Liu T, Mayer KH. Vulnerable periods: characterizing patterns of sexual risk and substance use during lapses in adherence to HIV pre-exposure prophylaxis among men who have sex with men. JAIDS J Acquir Immune Defic Syndr. 2019;80(3):276\u201383. https:\/\/doi.org\/10.1097\/QAI.0000000000001914.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"5","key":"4435_CR5","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s10461-018-2309-9","volume":"23","author":"C Grov","year":"2019","unstructured":"Grov C, Rendina HJ, John SA, Parsons JT. Determining the roles that club drugs, marijuana, and heavy drinking play in PrEP medication adherence among gay and bisexual men: implications for treatment and research. AIDS Behav. 2019;23(5):1277\u201386. https:\/\/doi.org\/10.1007\/s10461-018-2309-9.","journal-title":"AIDS Behav"},{"issue":"4","key":"4435_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11904-020-00502-5","volume":"17","author":"M Spinelli","year":"2020","unstructured":"Spinelli M, Haberer J, Chai P, Castillo-Mancilla J, Anderson P, Gandhi M. Approaches to objectively measure antiretroviral medication adherence and drive adherence interventions. Curr HIV\/AIDS Rep. 2020;17(4):301\u201314. https:\/\/doi.org\/10.1007\/s11904-020-00502-5.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"5","key":"4435_CR7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11904-018-0413-0","volume":"15","author":"KM Bell","year":"2018","unstructured":"Bell KM, Haberer JE. Actionable adherence monitoring: technological methods to monitor and support adherence to antiretroviral therapy. Curr HIV\/AIDS Rep. 2018;15(5):388\u201396. https:\/\/doi.org\/10.1007\/s11904-018-0413-0.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"4435_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11904-018-0377-0","volume":"15","author":"JR Castillo-Mancilla","year":"2018","unstructured":"Castillo-Mancilla JR, Haberer JE. Adherence measurements in HIV: new advancements in pharmacologic methods and real-time monitoring. Curr HIV\/AIDS Rep. 2018;15(1):49\u201359. https:\/\/doi.org\/10.1007\/s11904-018-0377-0.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"4435_CR9","doi-asserted-by":"publisher","unstructured":"Ikeda C, Misaki D. Medication monitoring from Accelerometer data through a series of medication actions using neural network for medication adherence evaluation. In: 2022 IEEE International Conference on Big Data and Smart Computing (BigComp). IEEE; 2022:288\u2013291. https:\/\/doi.org\/10.1109\/BigComp54360.2022.00061.","DOI":"10.1109\/BigComp54360.2022.00061"},{"key":"4435_CR10","unstructured":"AARDEX Corporation. Medication Event Monitoring System (MEMS). https:\/\/www.aardexgroup.com\/solutions\/mems-adherence-hardware\/."},{"issue":"1","key":"4435_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cbpra.2016.02.004","volume":"24","author":"SW Taylor","year":"2017","unstructured":"Taylor SW, Psaros C, Pantalone DW, et al. Life-steps for PrEP adherence: demonstration of a CBT-based intervention to increase adherence to preexposure prophylaxis (PrEP) medication among sexual-minority men at high risk for HIV acquisition. Cogn Behav Pract. 2017;24(1):38\u201349. https:\/\/doi.org\/10.1016\/j.cbpra.2016.02.004.","journal-title":"Cogn Behav Pract"},{"issue":"2","key":"4435_CR12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s11606-016-3899-4","volume":"32","author":"A Silapaswan","year":"2017","unstructured":"Silapaswan A, Krakower D, Mayer KH. Pre-exposure prophylaxis: a narrative review of provider behavior and interventions to increase PrEP implementation in primary care. J GEN INTERN MED. 2017;32(2):192\u20138. https:\/\/doi.org\/10.1007\/s11606-016-3899-4.","journal-title":"J GEN INTERN MED"},{"issue":"2","key":"4435_CR13","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1097\/QAI.0000000000002854","volume":"89","author":"PR Chai","year":"2022","unstructured":"Chai PR, Mohamed Y, Bustamante MJ, et al. DigiPrEP: a pilot trial to evaluate the feasibility, acceptability, and accuracy of a digital pill system to measure PrEP adherence in men who have sex with men who use substances. JAIDS J Acquir Immune Defic Syndr. 2022;89(2):e5\u201315. https:\/\/doi.org\/10.1097\/QAI.0000000000002854.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"7","key":"4435_CR14","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1007\/s10461-022-03594-9","volume":"26","author":"PR Chai","year":"2022","unstructured":"Chai PR, Goodman GR, Bronzi O, et al. Real-world user experiences with a Digital Pill System to measure PrEP adherence: perspectives from MSM with Substance Use. AIDS Behav. 2022;26(7):2459\u201368. https:\/\/doi.org\/10.1007\/s10461-022-03594-9.","journal-title":"AIDS Behav"},{"issue":"6","key":"4435_CR15","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s10461-020-03082-y","volume":"25","author":"PR Chai","year":"2021","unstructured":"Chai PR, Goodman G, Bustamante M, et al. Design and delivery of real-time adherence data to men who have sex with men using antiretroviral pre-exposure prophylaxis via an ingestible electronic sensor. AIDS Behav. 2021;25(6):1661\u201374. https:\/\/doi.org\/10.1007\/s10461-020-03082-y.","journal-title":"AIDS Behav"},{"issue":"10","key":"4435_CR16","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s10461-015-1272-y","volume":"20","author":"TB Wray","year":"2016","unstructured":"Wray TB, Kahler CW, Monti PM. Using Ecological Momentary Assessment (EMA) to study sex events among very high-risk men who have sex with men (MSM). AIDS Behav. 2016;20(10):2231\u201342. https:\/\/doi.org\/10.1007\/s10461-015-1272-y.","journal-title":"AIDS Behav"},{"issue":"6","key":"4435_CR17","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/s10461-019-02760-w","volume":"24","author":"TB Wray","year":"2020","unstructured":"Wray TB, Monti PM. Characteristics of sex events, partners, and motivations and their associations with HIV-Risk Behavior in a Daily Diary Study of High-Risk men who have sex with men (MSM). AIDS Behav. 2020;24(6):1851\u201364. https:\/\/doi.org\/10.1007\/s10461-019-02760-w.","journal-title":"AIDS Behav"},{"issue":"12","key":"4435_CR18","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1111\/add.15053","volume":"115","author":"TB Wray","year":"2020","unstructured":"Wray TB, Monti PM, Kahler CW, Guigayoma JP. Using ecological momentary assessment (EMA) to explore mechanisms of alcohol-involved HIV risk behavior among men who have sex with men (MSM). Addiction. 2020;115(12):2293\u2013302. https:\/\/doi.org\/10.1111\/add.15053.","journal-title":"Addiction"},{"issue":"3","key":"4435_CR19","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.2196\/jmir.7138","volume":"19","author":"LE Burke","year":"2017","unstructured":"Burke LE, Shiffman S, Music E, et al. Ecological Momentary Assessment in behavioral research: addressing Technological and Human Participant challenges. J Med Internet Res. 2017;19(3):e77. https:\/\/doi.org\/10.2196\/jmir.7138.","journal-title":"J Med Internet Res"},{"issue":"4","key":"4435_CR20","doi-asserted-by":"publisher","first-page":"e26213","DOI":"10.2196\/26213","volume":"5","author":"P Chai","year":"2021","unstructured":"Chai P, Bustamante M, Goodman G, et al. A brief training program to support use of a digital pill system for medication adherence. JMIR Formative Res. 2021;5(4):e26213. https:\/\/doi.org\/10.2196\/26213.","journal-title":"JMIR Formative Res"},{"issue":"2","key":"4435_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"issue":"4","key":"4435_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s13181-015-0494-8","volume":"11","author":"PR Chai","year":"2015","unstructured":"Chai PR, Castillo-Mancilla J, Buffkin E, et al. Utilizing an ingestible biosensor to assess real-time medication adherence. J Med Toxicol. 2015;11(4):439\u201344. https:\/\/doi.org\/10.1007\/s13181-015-0494-8.","journal-title":"J Med Toxicol"},{"key":"4435_CR23","unstructured":"etectRx. ID-Cap System. www.etectrx.com\/."},{"issue":"9\u201310","key":"4435_CR24","first-page":"12","volume":"13","author":"GP Flores","year":"2016","unstructured":"Flores GP, Peace B, Carnes TC, et al. Performance, reliability, usability, and safety of the ID-Cap system for ingestion event monitoring in healthy volunteers: a pilot study. Innov Clin Neurosci. 2016;13(9\u201310):12\u20139.","journal-title":"Innov Clin Neurosci"},{"issue":"11","key":"4435_CR25","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1097\/QAD.0000000000000647","volume":"29","author":"JE Haberer","year":"2015","unstructured":"Haberer JE, Bangsberg DR, Baeten JM, et al. Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm. AIDS. 2015;29(11):1277\u201385. https:\/\/doi.org\/10.1097\/QAD.0000000000000647.","journal-title":"AIDS"},{"issue":"5","key":"4435_CR26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/QAI.0000000000002382","volume":"84","author":"JE Egan","year":"2020","unstructured":"Egan JE, Ho K, Stall R, et al. Feasibility of short-term PrEP Uptake for men who have sex with men with episodic periods of increased HIV risk. J Acquir Immune Defic Syndr. 2020;84(5):508\u201313. https:\/\/doi.org\/10.1097\/QAI.0000000000002382.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"4435_CR27","doi-asserted-by":"publisher","first-page":"21472","DOI":"10.7448\/IAS.20.1.21472","volume":"20","author":"B Hoagland","year":"2017","unstructured":"Hoagland B, Moreira RI, De Boni RB, et al. High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV infection: the PrEP Brasil demonstration project. J Int AIDS Soc. 2017;20(1):21472. https:\/\/doi.org\/10.7448\/IAS.20.1.21472.","journal-title":"J Int AIDS Soc"},{"issue":"16","key":"4435_CR28","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1097\/QAD.0000000000001615","volume":"31","author":"M Gandhi","year":"2017","unstructured":"Gandhi M, Murnane PM, Bacchetti P, et al. Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men\/transwomen. AIDS. 2017;31(16):2245\u201351. https:\/\/doi.org\/10.1097\/QAD.0000000000001615.","journal-title":"AIDS"},{"issue":"1","key":"4435_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/QAI.0000000000001179","volume":"74","author":"SG Hosek","year":"2017","unstructured":"Hosek SG, Rudy B, Landovitz R, et al. An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM. JAIDS J Acquir Immune Defic Syndr. 2017;74(1):21\u20139. https:\/\/doi.org\/10.1097\/QAI.0000000000001179.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"4435_CR30","doi-asserted-by":"publisher","unstructured":"Camp C, Saberi P. Facilitators and barriers of 2-1-1 HIV pre-exposure prophylaxis. Patel RR, ed. PLoS ONE. 2021;16(5):e0251917. https:\/\/doi.org\/10.1371\/journal.pone.0251917.","DOI":"10.1371\/journal.pone.0251917"},{"issue":"10","key":"4435_CR31","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1093\/cid\/ciaa474","volume":"71","author":"JC Hojilla","year":"2020","unstructured":"Hojilla JC, Marcus JL, Silverberg MJ, et al. Early adopters of event-driven human immunodeficiency virus pre-exposure prophylaxis in a large healthcare system in San Francisco. Clin Infect Dis. 2020;71(10):2710\u20132. https:\/\/doi.org\/10.1093\/cid\/ciaa474.","journal-title":"Clin Infect Dis"},{"key":"4435_CR32","doi-asserted-by":"publisher","unstructured":"Corneli A, Perry B, Agot K, Ahmed K, Malamatsho F, Van Damme L. Facilitators of Adherence to the Study Pill in the FEM-PrEP Clinical Trial. Garcia-Lerma JG, ed. PLoS ONE. 2015;10(4):e0125458. https:\/\/doi.org\/10.1371\/journal.pone.0125458.","DOI":"10.1371\/journal.pone.0125458"},{"key":"4435_CR33","doi-asserted-by":"publisher","unstructured":"Haberer JE, Bangsberg DR, Baeten JM, et al. Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm. AIDS. 2015;29(11):1277-1285. https:\/\/doi.org\/10.1097\/QAD.0000000000000647.","DOI":"10.1097\/QAD.0000000000000647"},{"key":"4435_CR34","doi-asserted-by":"publisher","unstructured":"Liu H, Wang Y, Huang Y, et al. Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: an open-label, usual care-controlled, randomised trial. eBioMedicine Published Online November. 2022;104330. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104330.","DOI":"10.1016\/j.ebiom.2022.104330"},{"issue":"2","key":"4435_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s13181-024-01000-5","volume":"20","author":"JS Lee","year":"2024","unstructured":"Lee JS, Browning E, Hokayem J, et al. Smartphone and wearable device-based Digital phenotyping to Understand Substance use and its Syndemics. J Med Toxicol. 2024;20(2):205\u201314. https:\/\/doi.org\/10.1007\/s13181-024-01000-5.","journal-title":"J Med Toxicol"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-024-04435-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-024-04435-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-024-04435-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T05:06:38Z","timestamp":1727327198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-024-04435-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["4435"],"URL":"https:\/\/doi.org\/10.1007\/s10461-024-04435-7","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"assertion":[{"value":"27 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the Fenway Community Health Institutional Review Board (IRB). The procedures used in this study were in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Informed consent was obtained from all participants in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Peter R. Chai is on the medical advisory board of Biobot Analytics and a consultant for Syntis Bio and Equalizer Future Health. The other authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}